thought leadership
Trends 2024: Embracing technological disruption to drive medical engagement
Milo Elmir, Head of Experience Design and Gary Lyons, Head of Commercial, Medical | November 24, 2023
In the first part of our 2024 trends series, medical engagement experts Milo Elmir and Gary Lyons explore the technological disruption impacting customer engagement and give tangible advice for future-proofing your strategy.
In today’s rapidly evolving world, the biopharmaceutical industry finds itself at the epicenter of a monumental shift driven by broad technological disruption and a much deeper understanding of all stakeholder audience needs.
From research and development to manufacturing, distribution, and patient and medical engagement, every facet of the biopharmaceutical landscape has been profoundly impacted by this wave of advancement. It has not only revolutionized technologies, processes, and operational models but it has also reshaped the expectations of and demands on both internal and external stakeholders.
The traditional paradigms that once guided the biopharmaceutical sector are quickly becoming obsolete as organizations grapple with the need to adapt to disruptive digital transformation. Failing to keep pace has left many organizations struggling to maintain relevance in an increasingly competitive landscape, leading to setbacks in efficiency, competitiveness, and ultimately patient outcomes.
In this short paper, we explore the profound impact of technological disruption on medical engagement in the biopharmaceutical industry. We will:
· Explain what good looks like
· Delve into the complex challenges faced by organizations and the immense opportunities that lie within a well-executed digital transformation strategy
· Outline the key principles and strategies to guide biopharmaceutical organizations in their journey toward successful digital transformation.
Download the article to kick-start your digital strategy.